Next generation sequencing
Next-generation sequencing (NGS), .otherwise called greatly parallel sequencing, speaks to a viable approach to catch a lot of genomic data. Cutting edge sequencing is reforming therapeutic hereditary qualities and sooner rather than later will infest every single restorative field. Next-generation sequencing (NGS) advances are empowering synchronous sequencing of all applicable infection qualities, the exome or even the whole genome of patients looking for an atomic finding.
Related Conferences:
International Conference on Biochemistry October 13-15, 2016 Kuala Lumpur, Malaysia; World Congress on Amino Acids and Proteins December 08-09, 2016 Baltimore, USA; 5th International Conference on Computational Systems Biology August 22-23, 2016 Philadelphia, USA; 5th International Conference and Exhibition on Metabolomics May 16-18, 2016 Osaka, Japan; 6th International Conference on Bioinformatics March 29-30, 2016 Valencia, Spain, USA; International Conference on Structural Biology June 23-24, 2016 New Orleans; The DNA Damage Response in Cell Physiology and Disease October 5–9, 2015 Cape Sounio, Greece, Structure-Specific Endonucleases in Genome Stability Meeting November 04–06, 2015 Brno, Czech Republic; Maintenance of Genome Stability March 07-10, 2016. Panama, Mechanisms of Recombination Conference May 16-20, 2016 Alicante, Spain; Dynamic DNA and RNA Structures in Damage Responses & Cancer Conference Cancun, Mexico
- Developments in NGS analysis technologies
- Integration of technologies and data sets
- Latest Advances of NGS in Therapeutics & Genomic Medicine
- NGS: Clinical Applications & Diagnostics
- NGS Technologies & Platforms in Genomics and Genetics Research
Related Conference of Next generation sequencing
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
19th International Conference on Human Genomics and Genomic Medicine
17th International Conference on Human Genetics and Genetic Diseases
1st EMBL Conference Cancer Genomics Heidelberg Germany
Genomic Sample Prep and Biomarker Assay Development DNA RNA Extraction NGS Assays Liquid Biopsy Antibody Validation More San Francisco United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
Genomics Sequencing Data Integration Analysis and Visualization San Francisco United States of America
New Fronteirs in Gene Editing San Francisco United States of America
HPLC Congress 2016 London United Kingdom
2016 Genetics and Genomics Conference Vienna Austria
Genome Editing and Engineering Conference San Diego United States of America
Keystone Symposia Stem Cells and Cancer Breckenridge United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
Human Genomics Singapore Singapore
The Probiotics Congress Asia Kuala Lumpur Malaysia
Next generation sequencing Conference Speakers
Recommended Sessions
- Bioprocess Engineering and Biomarkers
- Cancer Genomics
- Chromosomal Abnormalities
- Clinical applications and diagnostics
- Cytogenetics
- Ecogenomics
- Evolution of Novel Genes
- Gene Expression, Regulation And Cloning
- Gene Mapping
- Genetic counseling
- Genetic Disorders Tests
- Genetic engineering techniques
- Genetic Testing Market
- Genetically modified organisms
- Genomic analysis
- Genomic data
- Genomic medicine
- Global DNA and Gene Chip (Microarrays)
- Medical genomics
- Microbial genetics
- Molecular Medicine
- Next generation sequencing
- Novel medical Devices
- Pedigree Methods
- Personalised genomics
- Pharmacogenetics
- Polygenic inheritance
- Prenatal diagnosis
- Reprogenetics
- Teratogenesis and their effects
- Tissue culture techniques
- Tissue Engineering and Regeneration
- Transgenic Research
- Tumor Markers
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Adult Stem Cells and Tissue-Specific Regeneration - Regenerative Medicine_2026 (France)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cardiovascular Regeneration and Stem Cell Therapeutics - Regenerative Medicine_2026 (France)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Embryonic Stem Cells and Pluripotent Stem Cells - Regenerative Medicine_2026 (France)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Hematopoietic Stem Cell Transplantation - Regenerative Medicine_2026 (France)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) - Regenerative Medicine_2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications - Regenerative Medicine_2026 (France)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Orthopedic Regenerative Medicine and Bone Tissue Engineering - Regenerative Medicine_2026 (France)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regenerative Medicine: Current Advances and Future Perspectives - Regenerative Medicine_2026 (France)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Regenerative Medicine_2026 (France)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cell Therapy for Neurological Disorders - Regenerative Medicine_2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)

